Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/08/2010CN101906156A Structures and application of bifunctional protein and derivatives of bifunctional protein
12/08/2010CN101906106A Novel heterocyclic compounds as HSP90-inhibitors
12/08/2010CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
12/08/2010CN101906076A Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof
12/08/2010CN101906054A N-(3,4-dyhydroxy benzoyl)-3,4-dyhydroxy benzamide and preparation method and application thereof
12/08/2010CN101905027A Oral pharmaceutical composition containing mitiglinide calcium and cyclodextrin
12/08/2010CN101904994A Chinese medicinal preparation for treating diabetes mellitus
12/08/2010CN101904983A Internal medicament for treating diabetes
12/08/2010CN101904971A Chinese medicinal composition for preventing and treating obesity and preparation thereof
12/08/2010CN101904946A Full-effect tea-lavender fat-suppression formulation with natural activity
12/08/2010CN101904925A Traditional Chinese medicine composite for treating hyperlipidaemia
12/08/2010CN101904916A Medicine for treating diabetes radically and preparation method thereof
12/08/2010CN101904907A Buckwheat extract abundant in inositol and general flavone and preparation method thereof
12/08/2010CN101904891A Ginkgo leaf pills and preparation method thereof
12/08/2010CN101904882A Preparation method of lithocarpus litseifolius total flavone
12/08/2010CN101904869A Method for preparing animal semen freeze-dried powder
12/08/2010CN101904868A Application of medicinal carbon in preparation of medicaments for curing hyperphosphatemia
12/08/2010CN101904862A Water-soluble vitamin composition freeze-drying preparation for injection
12/08/2010CN101904861A Application of Saccharomyces cerevisiae RNA in preparing medicine for promoting biologic metabolism and immunity
12/08/2010CN101904856A Application of 1,6-diphosphofructose and derivative thereof in preparing animal medical health care products
12/08/2010CN101904845A Amlodipine nicotinate with synergetic pressure reducing function and treatment composition thereof with statin drugs
12/08/2010CN101904844A Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative
12/08/2010CN101904841A Phenylphthalimide analog and its application for preparing diabetic macular edema drugs
12/08/2010CN101904840A Medicinal composition for treating type 2 diabetes of mammal including human
12/08/2010CN101904834A Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition
12/08/2010CN101904833A Salvianic acid A medical composition and preparation method thereof
12/08/2010CN101904829A Drug osmotic pump preparation
12/08/2010CN101904821A Quercetin nano freeze-dried powder and preparation method thereof
12/08/2010CN101904820A Quercetin nanosuspension freeze-drying composition and preparation method and application thereof
12/08/2010CN101904819A Method for preparing taurine particles
12/08/2010CN101586103B RNA interference sequence of glucagon receptor gene
12/08/2010CN101463055B O-indican compounds, preparation and use thereof
12/08/2010CN101391072B Traditional Chinese medicine for treating diabetic diarrhea
12/08/2010CN101375962B Formulation for activating blood and freeing collateral vessels and preparation method thereof
12/08/2010CN101367881B High-efficiency preparation method for glossy ganoderma polysaccharide
12/08/2010CN101365463B Antacid
12/08/2010CN101337075B Liquid state vitamine C production method thereof
12/08/2010CN101249116B Waxberry polyphenol chromocor extract, and preparations and applications thereof
12/08/2010CN101220021B 4-substituted phenoxyl quinoline compounds and midbody, production method, application thereof
12/08/2010CN101219157B method for preparing product for reducing blood sugar
12/08/2010CN101194726B Movement nutrition food
12/08/2010CN101156915B Traditional Chinese medicine valid target composition of preventing and treating diabetes as well as preparation and application
12/08/2010CN101129355B Lovastatin sustained-release tablets and method of producing the same
12/08/2010CN101129345B Vitamin K1 injection and method of producing the same
12/08/2010CN101125177B Fermented glutinous wine for treating diabetes
12/08/2010CN101107254B Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of cns disorders
12/08/2010CN101087598B Solid preparation containing reduced coenzyme Q10 and method for producing the same
12/08/2010CN101062408B Oral insulin compound medicine preparation and its preparing method
12/08/2010CN101018537B Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7846943 Hormone sensitive diseases; atherosclerosis; cardiovascular disorders; congestive heart failure; antidiabetic agents; metaboolism disorders; reducing triglycweride concentration
12/07/2010US7846911 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia
12/07/2010CA2588662C New 3-phenylpropionic acid derivatives for the treatment of diabetes
12/07/2010CA2488334C 24-sulfoximine vitamin d3 compounds
12/07/2010CA2482574C Method for the food-technological preparation of potato juice products
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/07/2010CA2394622C Stabilisation of pigments and polyunsaturated oils and oil concentrates
12/07/2010CA2390215C Phaseolamin compositions and methods for using the same
12/05/2010CA2678614A1 Extraction of broccoli juice for animal feed mixes, food colorants, source ingredient for pharmaceuticals, and food supplements
12/02/2010WO2010138802A2 Compositions and their use for removing cholesterol
12/02/2010WO2010138535A1 Methods for treating type 2 diabetes in patients resistant to previous treatment with other anti-diabetic drugs employing an sglt2 inhibitor and compositions thereof
12/02/2010WO2010137944A1 Treatment of hypercalcaemia
12/02/2010WO2010137875A2 Composition containing a bean extract for improving blood circulation and increasing vascular health
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137594A1 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010136847A1 Coated metformin with pioglitazone solution
12/02/2010WO2010135944A1 Salts of methyl (r)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate
12/02/2010WO2010135858A1 Pharmaceutical composition and use for preparing medicament thereof
12/02/2010WO2010117738A3 Solid state forms of sitagliptin salts
12/02/2010WO2010103547A3 Substituted fused pyrimidine compounds
12/02/2010WO2010035219A3 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
12/02/2010WO2010021879A3 Use of ultrarapid acting insulin
12/02/2010WO2009136219A8 Compositions comprising galactomannan and a process thereof
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305212 Therapeutic compounds
12/02/2010US20100305207 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
12/02/2010US20100305205 Composition and/or method for preventing recurrence of stroke
12/02/2010US20100305204 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305177 Prophylactic or therapeutic agent for diabetic maculopathy
12/02/2010US20100305174 Novel Heterocyclic Derivatives
12/02/2010US20100305162 Methods for the Synthesis of Pyridoxamine
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305143 Pyrrolopyrimidine compounds
12/02/2010US20100305142 3-aminoimidazo 1,2-a pyridine derivatives having an sglt1- and sglt2-inhibiting action for the treatment of type 1 and type 2 diabetes
12/02/2010US20100305139 Method of treating abnormal lipid metabolism
12/02/2010US20100305138 Pyridyl derivatives and their use as therapeutic agents
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305121 Novel antagonists of the human fatty acid synthase thioesterase
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305110 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/02/2010US20100305108 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 1298